知镜 Cognispect · 医学文献与研究工作台

Review on the significance and clinical application of anti-p53 autoantibody detection.

Bu F, Ling ZN, Li P, Zhou B, Zhu WY, Wang JL, Liu X, Zhu TY, Du YA, Lang QL, Zhou LH, Jin ZY, Wang WJ, Li YX, Zhang YZ, Du XY, Ling ZQ.
Frontiers in immunology · 2026-10-06 · PMID 42903374

文献摘要

As a critical tumor suppressor gene, mutations in p53 often contribute to the initiation and progression of cancer. Anti-p53 autoantibody (p53-AAb), produced by the immune system in response to mutated p53 protein, can be detected in the blood during early stages of tumor development. As a non-invasive biomarker, p53-AAb demonstrates potential for early screening, auxiliary diagnosis, prognosis evaluation, and treatment monitoring across various cancer types. Based on current literature and evidence-based medical data, this Review Article provides an overview of the scientific rationale, technical aspects, and clinical applications of p53-AAb testing. It summarizes practical considerations to guide scientific research and clinical practice, with the aim of promoting standardized utilization of this biomarker.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。